SE9801992D0 - New 3-aryl-2-hydroxypropionic acid derivative I - Google Patents

New 3-aryl-2-hydroxypropionic acid derivative I

Info

Publication number
SE9801992D0
SE9801992D0 SE9801992A SE9801992A SE9801992D0 SE 9801992 D0 SE9801992 D0 SE 9801992D0 SE 9801992 A SE9801992 A SE 9801992A SE 9801992 A SE9801992 A SE 9801992A SE 9801992 D0 SE9801992 D0 SE 9801992D0
Authority
SE
Sweden
Prior art keywords
aryl
acid derivative
hydroxypropionic acid
new
novel
Prior art date
Application number
SE9801992A
Other languages
English (en)
Swedish (sv)
Inventor
Kjell Andersson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9801992A priority Critical patent/SE9801992D0/xx
Publication of SE9801992D0 publication Critical patent/SE9801992D0/xx
Priority to MA25591A priority patent/MA26634A1/fr
Priority to MA25592A priority patent/MA26635A1/fr
Priority to DZ990100A priority patent/DZ2800A1/xx
Priority to DZ990099A priority patent/DZ2799A1/xx
Priority to TW088108577A priority patent/TW548263B/zh
Priority to TW088108576A priority patent/TW446696B/zh
Priority to EEP200000720A priority patent/EE04772B1/xx
Priority to HU0103376A priority patent/HUP0103376A3/hu
Priority to NZ508452A priority patent/NZ508452A/en
Priority to PT99930060T priority patent/PT1084102E/pt
Priority to RU2000130189/04A priority patent/RU2214999C2/ru
Priority to CA002333938A priority patent/CA2333938C/en
Priority to CA002334374A priority patent/CA2334374A1/en
Priority to JP2000552085A priority patent/JP3554539B2/ja
Priority to PL99344681A priority patent/PL344681A1/xx
Priority to IDW20002669A priority patent/ID29457A/id
Priority to DE69911770T priority patent/DE69911770T2/de
Priority to EP99930060A priority patent/EP1084102B1/en
Priority to BR9910928-0A priority patent/BR9910928A/pt
Priority to IL13963599A priority patent/IL139635A0/xx
Priority to AU46672/99A priority patent/AU752262B2/en
Priority to ES99930060T priority patent/ES2209457T3/es
Priority to DK99930060T priority patent/DK1084102T3/da
Priority to SI9930452T priority patent/SI1084102T1/xx
Priority to ES99930059T priority patent/ES2205844T3/es
Priority to AT99930059T priority patent/ATE246674T1/de
Priority to PCT/SE1999/000942 priority patent/WO1999062871A1/en
Priority to SK1768-2000A priority patent/SK284642B6/sk
Priority to TR2000/03583T priority patent/TR200003583T2/xx
Priority to YUP-745/00A priority patent/RS49688B/sr
Priority to PCT/SE1999/000941 priority patent/WO1999062872A1/en
Priority to HR20000782A priority patent/HRP20000782B1/xx
Priority to KR1020007013662A priority patent/KR100625152B1/ko
Priority to PT99930059T priority patent/PT1084103E/pt
Priority to EP99930059A priority patent/EP1084103B1/en
Priority to CNB2005100687433A priority patent/CN1310881C/zh
Priority to AT99930060T priority patent/ATE251130T1/de
Priority to DE69910203T priority patent/DE69910203T2/de
Priority to US09/341,904 priority patent/US6258850B1/en
Priority to AU46671/99A priority patent/AU752261B2/en
Priority to HU0103226A priority patent/HUP0103226A3/hu
Priority to KR1020007013673A priority patent/KR20010052529A/ko
Priority to PL99345205A priority patent/PL195189B1/pl
Priority to EEP200000725A priority patent/EE04463B1/xx
Priority to DK99930059T priority patent/DK1084103T3/da
Priority to CN99809340A priority patent/CN1311772A/zh
Priority to US09/341,931 priority patent/US6630600B1/en
Priority to HK01105811.5A priority patent/HK1035711B/en
Priority to IDW20002652A priority patent/ID28833A/id
Priority to SK1769-2000A priority patent/SK284849B6/sk
Priority to NZ508453A priority patent/NZ508453A/xx
Priority to JP2000552084A priority patent/JP3723739B2/ja
Priority to BR9910921-2A priority patent/BR9910921A/pt
Priority to CZ20004484A priority patent/CZ297424B6/cs
Priority to IL13963699A priority patent/IL139636A/xx
Priority to HK01105768.8A priority patent/HK1034957B/en
Priority to UA2000116621A priority patent/UA71912C2/uk
Priority to SI9930405T priority patent/SI1084103T1/xx
Priority to CN99809354A priority patent/CN1312795A/zh
Priority to TR2000/03581T priority patent/TR200003581T2/xx
Priority to UA2000116620A priority patent/UA66852C2/uk
Priority to TNTNSN99108A priority patent/TNSN99108A1/fr
Priority to MYPI99002209A priority patent/MY117785A/en
Priority to TNTNSN99103A priority patent/TNSN99103A1/fr
Priority to MYPI99002185A priority patent/MY129581A/en
Priority to ARP990102635A priority patent/AR020875A1/es
Priority to ARP990102634A priority patent/AR035305A1/es
Priority to EG65699A priority patent/EG24140A/xx
Priority to SA99200304A priority patent/SA99200304B1/ar
Priority to ARP000102487A priority patent/AR024061A2/es
Priority to IS5714A priority patent/IS2071B/is
Priority to ZA200006774A priority patent/ZA200006774B/en
Priority to IS5744A priority patent/IS5744A/is
Priority to NO20006116A priority patent/NO20006116L/no
Priority to NO20006115A priority patent/NO323426B1/no
Priority to US09/861,163 priority patent/US20010034371A1/en
Priority to US10/039,868 priority patent/US6660879B2/en
Priority to JP2003273428A priority patent/JP2004043480A/ja
Priority to US10/669,131 priority patent/US20040229946A1/en
Priority to US10/678,739 priority patent/US20040229949A1/en
Priority to JP2004183263A priority patent/JP2004346079A/ja
Priority to US11/078,201 priority patent/US20060040979A1/en
Priority to US11/388,942 priority patent/US20060173204A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/30—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reactions not involving the formation of esterified sulfo groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/76—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and etherified hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/29—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/38—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/58—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/19—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/18—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE9801992A 1998-06-04 1998-06-04 New 3-aryl-2-hydroxypropionic acid derivative I SE9801992D0 (sv)

Priority Applications (84)

Application Number Priority Date Filing Date Title
SE9801992A SE9801992D0 (sv) 1998-06-04 1998-06-04 New 3-aryl-2-hydroxypropionic acid derivative I
MA25591A MA26634A1 (fr) 1998-06-04 1999-05-20 Nouveaux derives de l'acide 3-aryl propionique et analogues
MA25592A MA26635A1 (fr) 1998-06-04 1999-05-20 Nouveau derive i de l'acide 3-aryl-2-hydroxypropionique
DZ990100A DZ2800A1 (fr) 1998-06-04 1999-05-23 Nouveau dérivé de l'acide 3-aryl-2-hydroxypropionique.
DZ990099A DZ2799A1 (fr) 1998-06-04 1999-05-23 Nouveaux dérivés de l'acide 3-aryl propionique et analogues.
TW088108577A TW548263B (en) 1998-06-04 1999-05-25 New 3-aryl propionic acid derivatives and analogs
TW088108576A TW446696B (en) 1998-06-04 1999-05-25 New 3-aryl-2-hydroxypropionic acid derivative I
EEP200000720A EE04772B1 (et) 1998-06-04 1999-05-31 3-arüül-2-hüdroksüpropaanhappe derivaat (I)
HU0103376A HUP0103376A3 (en) 1998-06-04 1999-05-31 New 3-aryl-2-hydroxypropionic acid derivative, pharmaceutical compositions containing it, process for their preparation and their use
NZ508452A NZ508452A (en) 1998-06-04 1999-05-31 New 3-aryl-2-hydroxypropionic acid derivative (I)
PT99930060T PT1084102E (pt) 1998-06-04 1999-05-31 Novos derivados do acido 3-aril-propionico e analogos
RU2000130189/04A RU2214999C2 (ru) 1998-06-04 1999-05-31 Производное 3-арил-2-гидроксипропионовой кислоты, способ его получения(варианты), фармацевтический препарат, способ лечения и промежуточный продукт
CA002333938A CA2333938C (en) 1998-06-04 1999-05-31 New 3-aryl-2-hydroxypropionic acid derivative (i)
CA002334374A CA2334374A1 (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs
JP2000552085A JP3554539B2 (ja) 1998-06-04 1999-05-31 新規な３−アリール−２−ヒドロキシプロピオン酸誘導体ｉ
PL99344681A PL344681A1 (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs
IDW20002669A ID29457A (id) 1998-06-04 1999-05-31 Turunan dan analog asam 3-aril propionat
DE69911770T DE69911770T2 (de) 1998-06-04 1999-05-31 Neue 3-aryl-propionsäurederivate und analoge
EP99930060A EP1084102B1 (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs
BR9910928-0A BR9910928A (pt) 1998-06-04 1999-05-31 Composto, processo para a prepará-lo, uso do mesmo, formulação, e, processo para a profilaxia e/ou tratamento de condições clinicas associadas com resistência a insulina
IL13963599A IL139635A0 (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs
AU46672/99A AU752262B2 (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs
ES99930060T ES2209457T3 (es) 1998-06-04 1999-05-31 Nuevos derivados del acido 3-aril-propionico, y analogos.
DK99930060T DK1084102T3 (da) 1998-06-04 1999-05-31 Nye 3-arylpropionsyrederivater og analoge
SI9930452T SI1084102T1 (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs
ES99930059T ES2205844T3 (es) 1998-06-04 1999-05-31 Nuevo derivado (i) de acido 3-aril-2-hidroxipropionico.
AT99930059T ATE246674T1 (de) 1998-06-04 1999-05-31 Neue 3-aryl-2-hydroxypropionsäure-derivate
PCT/SE1999/000942 WO1999062871A1 (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs
SK1768-2000A SK284642B6 (sk) 1998-06-04 1999-05-31 Deriváty kyseliny 3-aryl-2-hydroxypropiónovej, farmaceutický prípravok s ich obsahom a ich použitie
TR2000/03583T TR200003583T2 (tr) 1998-06-04 1999-05-31 Yeni 3-aril propiyonik asit türevleri ve benzerleri.
YUP-745/00A RS49688B (sr) 1998-06-04 1999-05-31 Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
PCT/SE1999/000941 WO1999062872A1 (en) 1998-06-04 1999-05-31 New 3-aryl-2-hydroxypropionic acid derivative (i)
HR20000782A HRP20000782B1 (en) 1998-06-04 1999-05-31 New 3-aryl-2-hydroxypropionic acid derivative (i)
KR1020007013662A KR100625152B1 (ko) 1998-06-04 1999-05-31 신규한 3-아릴-2-히드록시프로피온산 유도체 (ｉ)
PT99930059T PT1084103E (pt) 1998-06-04 1999-05-31 Novo derivado do acido 3-aril-2-hidroxipropionico (i)
EP99930059A EP1084103B1 (en) 1998-06-04 1999-05-31 New 3-aryl-2-hydroxypropionic acid derivative (i)
CNB2005100687433A CN1310881C (zh) 1998-06-04 1999-05-31 新的3－芳基－2－羟基丙酸衍生物i
AT99930060T ATE251130T1 (de) 1998-06-04 1999-05-31 Neue 3-aryl-propionsäurederivate und analoge
DE69910203T DE69910203T2 (de) 1998-06-04 1999-05-31 Neue 3-aryl-2-hydroxypropionsäure-derivate
US09/341,904 US6258850B1 (en) 1998-06-04 1999-05-31 3-aryl-2-hydroxypropionic acid derivative (I)
AU46671/99A AU752261B2 (en) 1998-06-04 1999-05-31 New 3-aryl-2-hydroxypropionic acid derivative (I)
HU0103226A HUP0103226A3 (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs
KR1020007013673A KR20010052529A (ko) 1998-06-04 1999-05-31 신규한 3-아릴 프로피온산 유도체 및 동족체
PL99345205A PL195189B1 (pl) 1998-06-04 1999-05-31 Kwas (S)-2-etoksy-3-[4-(2-{4-metanosulfonyloksyfenylo}-etoksy)fenylo]propanowy, sposób jego wytwarzania, związki pośrednie, środek farmaceutyczny i zastosowanie kwasu (S)-2-etoksy-3-[4-(2-{4-metanosulfonyloksyfenylo}etoksy)fenylo]propanowego
EEP200000725A EE04463B1 (et) 1998-06-04 1999-05-31 3-arüülpropaanhappe derivaadid ja nende analoogid, nende valmistamise meetod, neid sisaldavad ravimkoostised ja ühendid kasutamiseks ravis
DK99930059T DK1084103T3 (da) 1998-06-04 1999-05-31 Nyt 3-aryl-2-hydroxpropionsyrederivat (I)
CN99809340A CN1311772A (zh) 1998-06-04 1999-05-31 新的3－芳基－2－羟基丙酸衍生物i
US09/341,931 US6630600B1 (en) 1998-06-04 1999-05-31 3-aryl propionic acid derivatives and analogs
HK01105811.5A HK1035711B (en) 1998-06-04 1999-05-31 New 3-aryl-2-hydroxypropionic acid derivative (i)
IDW20002652A ID28833A (id) 1998-06-04 1999-05-31 Turunan asam 3-aril-2-hidroksipropionat
SK1769-2000A SK284849B6 (sk) 1998-06-04 1999-05-31 Deriváty a analógy kyseliny 3-arylpropiónovej, spôsob ich prípravy, farmaceutické formulácie s ich obsahom a ich použitie
NZ508453A NZ508453A (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs and their use in the treatment of insulin resistance
JP2000552084A JP3723739B2 (ja) 1998-06-04 1999-05-31 新規３−アリールプロピオン酸誘導体および類似体
BR9910921-2A BR9910921A (pt) 1998-06-04 1999-05-31 Composto, processo para preparar o mesmo, formulação farmacêutica, uso de um composto, e, processo para a profilaxia e/ou tratamento de condições clìnicas associadas com a resistência à insulina
CZ20004484A CZ297424B6 (cs) 1998-06-04 1999-05-31 Kyselina (S)-2-ethoxy-3-{4-[2-(4-methansulfonyloxyfenyl)-ethoxy]fenyl}propanová, zpusob její prípravy, farmaceutický prostredek s jejím obsahem a její pouzití
IL13963699A IL139636A (en) 1998-06-04 1999-05-31 (s)-2-ethoxy-3-[4-(2{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid, process for its preparation, pharmaceutical composition containing it and use thereof in the manufacture of medicament for the prophylaxis or treatment of clinical conditions associated with insulin resistance
HK01105768.8A HK1034957B (en) 1998-06-04 1999-05-31 New 3-aryl propionic acid derivatives and analogs
UA2000116621A UA71912C2 (en) 1998-06-04 1999-05-31 3-aryl-2-hydroxypropionic acid derivative, a process for its manufacture (variants), intermediate compound, a pharmaceutical composition (variants) and a method for prevention and/or treatment of clinical conditions associated with insulin resistance
SI9930405T SI1084103T1 (en) 1998-06-04 1999-05-31 New 3-aryl-2-hydroxypropionic acid derivative (i)
CN99809354A CN1312795A (zh) 1998-06-04 1999-05-31 新的3－芳基丙酸衍生物和其类似物
TR2000/03581T TR200003581T2 (tr) 1998-06-04 1999-05-31 Yeni 3-aril-2-hidroksipropiyonik asit türevi (I)
UA2000116620A UA66852C2 (uk) 1998-06-04 1999-05-31 Похідні та аналоги 3-арилпропіонової кислоти, спосіб їх отримання, фармацевтична композиція (варіанти) та спосіб профілактики та/або лікування асоційованих з резистентністю до інсуліну клінічних станів
TNTNSN99108A TNSN99108A1 (fr) 1998-06-04 1999-06-02 Nouveau derive i de l'acide 3-aryl-2-hydroxypropionique
MYPI99002209A MY117785A (en) 1998-06-04 1999-06-02 New 3-aryl-2-hydroxypropionic acid derivatives i
TNTNSN99103A TNSN99103A1 (fr) 1998-06-04 1999-06-02 Nouveaux derives de l'acide 3-aryl propionique et analogues
MYPI99002185A MY129581A (en) 1998-06-04 1999-06-02 New 3-aryl propionic acid derivatives and analogs
ARP990102635A AR020875A1 (es) 1998-06-04 1999-06-03 Compuesto acido (s)-2-etoxi-3-[4-(2-(4-metansulfoniloxi fenil)etoxi)fenil]-propanoico, proceso para su preparacion formulaicon farmaceutica, uso de dicho compuesto en la elaboracion de medicamentos, y formulacion farmaceutica
ARP990102634A AR035305A1 (es) 1998-06-04 1999-06-03 Derivados y analogos del acido 3-arilpropionico, proceso para su preparacion, formulaciones farmaceuticas, uso de los mismos en la elaboracion de medicamentos, y formulacion farmaceutica para usar en la profilaxis y/o tratamiento de trastornos clinicos asociados con la resistencia a la insulina
EG65699A EG24140A (en) 1998-06-04 1999-06-03 New 3-aryl-2-hydroxypropionic acid derivative
SA99200304A SA99200304B1 (ar) 1998-06-04 1999-06-28 مشتق جديد رقم 1 لـــ -2-aryl-3 hydroxypropionic acid
ARP000102487A AR024061A2 (es) 1998-06-04 2000-05-22 Intermediario acido 2-etoxi-3(-(2[4-metansulfoniloxifenil*etoxi*fenil*propanoico
IS5714A IS2071B (is) 1998-06-04 2000-11-17 Ný 3-arýl-2-hýdroxýprópíonsýruafleiða (I)
ZA200006774A ZA200006774B (en) 1998-06-04 2000-11-20 New 3-aryl-2-hydroxypropionic acid derivative (I).
IS5744A IS5744A (is) 1998-06-04 2000-11-29 Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður
NO20006116A NO20006116L (no) 1998-06-04 2000-12-01 Nye 3-arylpropionsyrederivater og -analoger
NO20006115A NO323426B1 (no) 1998-06-04 2000-12-01 Nytt 3-aryl-2-hydroksypropionsyrederivat, fremgangsmate for fremstilling derav samt anvendelse derav i terapi
US09/861,163 US20010034371A1 (en) 1998-06-04 2001-05-18 New 3-aryl-2-hydroxypropionic acid derivative I
US10/039,868 US6660879B2 (en) 1998-06-04 2002-01-04 3-aryl-2-hydroxypropionic acid derivative I
JP2003273428A JP2004043480A (ja) 1998-06-04 2003-07-11 新規な３−アリール−２−ヒドロキシプロピオン酸誘導体ｉの中間体
US10/669,131 US20040229946A1 (en) 1998-06-04 2003-09-22 New 3-aryl-2-hydroxypropionic acid derivative I
US10/678,739 US20040229949A1 (en) 1998-06-04 2003-10-02 New 3-aryl propionic acid derivatives and analogs
JP2004183263A JP2004346079A (ja) 1998-06-04 2004-06-22 新規３−アリールプロピオン酸誘導体および類似体
US11/078,201 US20060040979A1 (en) 1998-06-04 2005-03-11 3-Aryl-2-hydroxypropionic acid derivative I
US11/388,942 US20060173204A1 (en) 1998-06-04 2006-03-24 New 3-aryl propionic acid derivatives and analogs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801992A SE9801992D0 (sv) 1998-06-04 1998-06-04 New 3-aryl-2-hydroxypropionic acid derivative I

Publications (1)

Publication Number Publication Date
SE9801992D0 true SE9801992D0 (sv) 1998-06-04

Family

ID=20411587

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801992A SE9801992D0 (sv) 1998-06-04 1998-06-04 New 3-aryl-2-hydroxypropionic acid derivative I

Country Status (39)

Country Link
US (5) US6258850B1 (enExample)
EP (1) EP1084103B1 (enExample)
JP (2) JP3554539B2 (enExample)
KR (1) KR100625152B1 (enExample)
CN (2) CN1311772A (enExample)
AR (2) AR020875A1 (enExample)
AT (1) ATE246674T1 (enExample)
AU (1) AU752261B2 (enExample)
BR (1) BR9910928A (enExample)
CA (1) CA2333938C (enExample)
CZ (1) CZ297424B6 (enExample)
DE (1) DE69910203T2 (enExample)
DK (1) DK1084103T3 (enExample)
DZ (1) DZ2800A1 (enExample)
EE (1) EE04772B1 (enExample)
EG (1) EG24140A (enExample)
ES (1) ES2205844T3 (enExample)
HR (1) HRP20000782B1 (enExample)
HU (1) HUP0103376A3 (enExample)
ID (1) ID28833A (enExample)
IL (1) IL139636A (enExample)
IS (1) IS2071B (enExample)
MA (1) MA26635A1 (enExample)
MY (1) MY117785A (enExample)
NO (1) NO323426B1 (enExample)
NZ (1) NZ508452A (enExample)
PL (1) PL195189B1 (enExample)
PT (1) PT1084103E (enExample)
RS (1) RS49688B (enExample)
RU (1) RU2214999C2 (enExample)
SA (1) SA99200304B1 (enExample)
SE (1) SE9801992D0 (enExample)
SK (1) SK284642B6 (enExample)
TN (1) TNSN99108A1 (enExample)
TR (1) TR200003581T2 (enExample)
TW (1) TW446696B (enExample)
UA (1) UA71912C2 (enExample)
WO (1) WO1999062872A1 (enExample)
ZA (1) ZA200006774B (enExample)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8702758D0 (en) * 1987-02-06 1987-03-11 Wellcome Found Treatment of disease
EP1629849B2 (en) 1997-01-07 2017-10-04 Amylin Pharmaceuticals, LLC Pharmaceutical compositions comprising exendins and agonists thereof
AU1198699A (en) * 1997-10-27 1999-04-23 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
MA26634A1 (fr) 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
GB0001662D0 (en) * 1999-02-06 2000-03-15 Zeneca Ltd Pharmaceutical compositions
SE9904415D0 (sv) * 1999-12-03 1999-12-03 Astra Ab New process
WO2001040171A1 (en) * 1999-12-03 2001-06-07 Astrazeneca Ab Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
TW574193B (en) * 1999-12-03 2004-02-01 Astrazeneca Ab Novel phenalkyloxy-phenyl derivatives, pharmaceutical composition containing the same and their uses
US7084177B2 (en) * 1999-12-03 2006-08-01 Astrazeneca Ab Comminuted form of(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
SE9904421D0 (sv) 1999-12-03 1999-12-03 Astra Ab New compounds
DK1246638T4 (da) * 2000-01-10 2014-09-22 Amylin Pharmaceuticals Llc Anvendelse af extendiner og agonister deraf til behandlingen af hypertriglyceridæmi
US6559335B2 (en) 2000-09-22 2003-05-06 Dr. Reddy's Laboratories Limited Process for the preparation of 3-aryl-2-hydroxy propanoic acid
WO2002051441A1 (en) 2000-12-26 2002-07-04 Sankyo Company, Limited Medicinal compositions containing diuretic and insulin resistance-improving agent
SE0101386D0 (sv) 2001-04-20 2001-04-20 Astrazeneca Ab New compounds
SE0101982D0 (sv) * 2001-06-01 2001-06-01 Astrazeneca Ab Pharmaceutical combination
SE0101981D0 (sv) * 2001-06-01 2001-06-01 Astrazeneca Ab Pharmaceutical combination
SE0101980D0 (sv) * 2001-06-01 2001-06-01 Astrazeneca Ab Pharmaceutical combination
SE0101978D0 (sv) 2001-06-01 2001-06-01 Astrazeneca Ab New compounds
JP2004528388A (ja) * 2001-06-01 2004-09-16 アストラゼネカ アクチボラグ ３−アリール−２−ヒドロキシプロピオン酸誘導体の製造法
PL368051A1 (en) 2001-06-07 2005-03-21 Eli Lilly And Company Modulators of peroxisome proliferator activated receptors
IL159320A0 (en) * 2001-06-12 2004-06-01 Wellstat Therapeutics Corp Compounds for the treatment of metabolic disorders
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
GB0314079D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0229931D0 (en) * 2002-12-21 2003-01-29 Astrazeneca Ab Therapeutic agents
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
WO2003059378A2 (en) 2001-12-29 2003-07-24 Novo Nordisk A/S Combined use of a glp-1 compound and another drug for treating dyslipidemia
SE0201005D0 (sv) * 2002-04-02 2002-04-02 Astrazeneca Ab New Process
US20050119314A1 (en) * 2002-04-05 2005-06-02 Sankyo Company, Limited Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
US7351858B2 (en) * 2002-06-20 2008-04-01 Astrazeneca Ab Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
SE0201936D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab Therapeutic agents
SE0201937D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab Therapeutic agents
TWI282784B (en) * 2002-06-20 2007-06-21 Astrazeneca Ab Therapeutic agents
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AP2005003462A0 (en) * 2003-06-06 2005-12-31 Cadila Healthcare Ltd Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution.
GB0314075D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314131D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314078D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314130D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314260D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
CA2546601A1 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
JP2007512222A (ja) * 2003-11-27 2007-05-17 高砂香料工業株式会社 光学活性３−（４−ヒドロキシフェニル）プロピオン酸類の製造方法
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
US7799804B2 (en) 2004-04-03 2010-09-21 Astrazeneca Ab Therapeutic agents
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
TW200608967A (en) 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
US8017633B2 (en) * 2005-03-08 2011-09-13 Nycomed Gmbh Roflumilast for the treatment of diabetes mellitus
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
WO2008010238A2 (en) * 2006-07-21 2008-01-24 Lupin Limited Antidiabetic azabicyclo [3. 1. 0] hexan compounds
KR100958831B1 (ko) * 2006-09-19 2010-05-24 주식회사유한양행 헤테로아릴피리미딘 유도체, 이들의 제조방법, 및 이들을포함하는 조성물
US20090082441A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched tesaglitazar
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
KR101890959B1 (ko) 2010-11-04 2018-08-22 알비레오 에이비 간질환 치료를 위한 ｉｂａｔ 억제제
CN103228270B (zh) 2010-11-08 2016-02-10 阿尔比里奥公司 含ibat抑制剂和胆汁酸结合剂的药物组合
WO2013041621A1 (de) 2011-09-20 2013-03-28 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung
BR112015024859A2 (pt) * 2013-03-27 2017-10-10 Pfizer Ireland Pharmaceuticals processo e intermediários para a preparação de pregabalina
MX2016000724A (es) * 2013-07-22 2016-04-13 Metabolic Solutions Dev Co Llc Compuestos de reserva de los receptores activados del proliferador de peroxisoma (ppar) para el tratamiento de enfermedades metabolicas.
CN120091812A (zh) 2022-11-08 2025-06-03 基恩菲特公司 用于治疗肝衰竭的PPARα/γ激动剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4114417A (en) * 1977-06-27 1978-09-19 Schmelzer Corporation Method and apparatus for making metal parts
US4479005A (en) * 1982-12-16 1984-10-23 The Dow Chemical Company Selective preparation of isomers and enantiomers of cyclopropane carboxylic acids
FR2653119B1 (fr) 1989-10-18 1994-08-05 Lipha Nouveaux aryloxy alcoyl benzenes, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
US5068345A (en) * 1989-10-30 1991-11-26 Eastman Kodak Company Oxazolidinone aldol adduct
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
GB9114948D0 (en) * 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
EP1000938A1 (en) * 1992-07-03 2000-05-17 Smithkline Beecham Plc Heterocyclic compounds as pharmaceuticals
US5232945A (en) 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
US5648541A (en) * 1995-09-28 1997-07-15 Nps Pharmaceuticals, Inc. Chiral reductions of imines leading to the syntheses of optically active amines
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
KR20000005224A (ko) * 1996-04-04 2000-01-25 가와무라 요시부미 페닐알킬카르복실산 유도체_
AU749505B2 (en) * 1997-10-27 2002-06-27 Dr. Reddy's Laboratories Limited Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
BR9910928A (pt) 2001-02-13
HRP20000782B1 (en) 2004-04-30
HK1035711A1 (en) 2001-12-07
YU74500A (sh) 2002-12-10
JP3554539B2 (ja) 2004-08-18
IL139636A0 (en) 2002-02-10
DE69910203T2 (de) 2004-06-17
EE200000720A (et) 2002-04-15
DK1084103T3 (da) 2003-11-17
EP1084103A1 (en) 2001-03-21
US20030027859A1 (en) 2003-02-06
CN1311772A (zh) 2001-09-05
MA26635A1 (fr) 2004-12-20
IS2071B (is) 2005-12-15
CZ297424B6 (cs) 2006-12-13
CN1680308A (zh) 2005-10-12
NO20006115D0 (no) 2000-12-01
EE04772B1 (et) 2007-02-15
US20040229946A1 (en) 2004-11-18
IL139636A (en) 2005-08-31
TW446696B (en) 2001-07-21
US6258850B1 (en) 2001-07-10
NO20006115L (no) 2001-02-07
CZ20004484A3 (en) 2001-06-13
NZ508452A (en) 2003-05-30
ATE246674T1 (de) 2003-08-15
TNSN99108A1 (fr) 2005-11-10
AR024061A2 (es) 2002-09-04
UA71912C2 (en) 2005-01-17
DE69910203D1 (en) 2003-09-11
JP2004043480A (ja) 2004-02-12
ZA200006774B (en) 2002-02-20
AU752261B2 (en) 2002-09-12
US20010034371A1 (en) 2001-10-25
NO323426B1 (no) 2007-04-30
CA2333938C (en) 2007-08-07
SA99200304B1 (ar) 2006-10-04
MY117785A (en) 2004-08-30
RS49688B (sr) 2007-12-31
HRP20000782A2 (en) 2001-06-30
US20060040979A1 (en) 2006-02-23
AR020875A1 (es) 2002-06-05
CN1310881C (zh) 2007-04-18
DZ2800A1 (fr) 2003-12-01
HUP0103376A2 (hu) 2002-05-29
TR200003581T2 (tr) 2001-06-21
SK17682000A3 (sk) 2001-08-06
WO1999062872A1 (en) 1999-12-09
JP2002516900A (ja) 2002-06-11
KR20010052521A (ko) 2001-06-25
HUP0103376A3 (en) 2005-03-29
ID28833A (id) 2001-07-05
EP1084103B1 (en) 2003-08-06
CA2333938A1 (en) 1999-12-09
IS5714A (is) 2000-11-17
EG24140A (en) 2008-08-06
SK284642B6 (sk) 2005-08-04
AU4667199A (en) 1999-12-20
PL195189B1 (pl) 2007-08-31
PL345205A1 (en) 2001-12-03
US6660879B2 (en) 2003-12-09
RU2214999C2 (ru) 2003-10-27
ES2205844T3 (es) 2004-05-01
PT1084103E (pt) 2003-12-31
KR100625152B1 (ko) 2006-09-20

Similar Documents

Publication Publication Date Title
SE9801992D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative I
MY129581A (en) New 3-aryl propionic acid derivatives and analogs
SE9801990D0 (sv) New 3-aryl propionic acid derivatives and analogs
EA200000711A1 (ru) 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, СПОСОБ ПОЛУЧЕНИЯ ФАРМАЦЕВТИЧЕСКИХ ПРЕПАРАТОВ, СОДЕРЖАЩИХ ЭТИ 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, И ИХ ПРИМЕНЕНИЕ ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
NZ515902A (en) Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, and type 2 diabetes
SE0001899D0 (sv) New compounds
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
EA200300323A1 (ru) ПРОИЗВОДНЫЕ ГУАНИДИНОБЕНЗАМИДА (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ ОПОСРЕДОВАННОГО mc4-r ЗАБОЛЕВАНИЯ (ВАРИАНТЫ)
SE9702305D0 (sv) New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
DE3877406D1 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
CA2262566A1 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
DE69909209D1 (de) Pyrimidinon-derivate, diese verbindungen enthaltenden pharmazeutische zubereitungen und verfharen zu ihrer herstellung
AU2002230543A1 (en) Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
SE9904421D0 (sv) New compounds
BG102623A (bg) Нови производни на бензоилгуанидина, методи за тяхното получаване и приложението им за производството на ле- карствени средства
EP1663201A4 (en) USE OF NOVEL 2-OXO-HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
ATE172721T1 (de) Aminosäurederivate und ihre verwendung als enkephalinase-inhibitoren
BR0012622A (pt) Derivados de 3-amino-2-benzil-1-fenil-propano
ATE85328T1 (de) Substituierte toluidine, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer.
DE3674521D1 (de) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte.
ATE244246T1 (de) Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE3682370D1 (de) 3-aminocarbonyl-1,4-dihydropyridin-5-carboxylsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zusammensetzungen.
EA200100317A1 (ru) Новые производные бензоилгуанидина с эффективными свойствами, способ их получения и их применение при изготовлении лекарственных средств